BRUSSELS (Reuters) - The European Commission on Thursday said it had fined five pharmaceutical companies for a total of 13.4 million euros ($14.1 million) in a settlement of an antitrust investigation.
The commission fined Alkaloids of Australia, Alkaloids Corporation, Boehringer, Linnea and Transo-Pharm for participating in a cartel aimed at fixing the minimum price of an ingredient to produce the abdominal antispasmodic drug Buscopan and its generic versions.
($1 = 0.9489 euros)
(Reporting by Bart Meijer, Editing by Charlotte Van Campenhout)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 2,747 PTS | +0.54% | -0.31% | - | ||
| 13,595 PTS | -3.95% | -8.97% | - | ||
